Idiopathic Ulcerative Laryngitis (IUL): An Indian Perspective.
Autor: | Manjunath MK; Manipal Hospital Yeshwanthpur, Bengaluru, 560055 India., Sachidananda R; People Tree Hospital, Goraguntepalya, Bengaluru, 560022 India., Sreenivasa Murthy TM; Manipal Hospital Yeshwanthpur, Bengaluru, 560055 India., Jyothi Swarup R; Sree Siddhartha Medical College, Tumkur, Karnataka 572102 India., Venkataramani N; ENT, People Tree Hospital, Goraguntepalya, Bengaluru, 560022 India. |
---|---|
Jazyk: | angličtina |
Zdroj: | Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India [Indian J Otolaryngol Head Neck Surg] 2023 Sep; Vol. 75 (3), pp. 2217-2221. Date of Electronic Publication: 2023 May 07. |
DOI: | 10.1007/s12070-023-03833-y |
Abstrakt: | Idiopathic ulcerative laryngitis (IUL) is characterized by bilateral ulceration of vocal cords which is followed by a protracted course of healing. It is rarely diagnosed, with a paucity of published data in English literature. There is no published data on this topic in the Indian population. Twenty-one patients from 3 centres were prospectively evaluated for clinical presentation, diagnosis, treatment, and follow-up. All patients underwent fibreoptic laryngoscopic evaluation and stroboscopic assessment. They were treated with supportive care and stringent follow-up. 21 patients with a median age of 39 years were included. This condition was commonly seen in males. All patients were treated conservatively except two who underwent a biopsy. The average time for full recovery in 14 of our patients who had compliant follow-ups was 9.24 weeks. GRBAS score improved from 9 to 5.93( p < 0.0001). Self-reported voice outcomes improved in all patients except for one patient who had a biopsy. IUL is uncommon but not rare in the Indian population. It shows full recovery with conservative management that involves at least more than 3-4 weeks. Competing Interests: Conflict of interestNone. (© Association of Otolaryngologists of India 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |